µ |
µ1, µ2, µ3
|
Mu receptor/MOP/OP3/MOPr/opioid receptor, mu 1 |
spinal and supraspinal analgesia
respiratory and cardiac depression
euphoria
sedation
physical dependence
tolerance
changes of smooth muscle tone
decreased gastrointestinal motility
urinary retention
pruritus
|
δ |
δ1, δ2
|
DOP/DOR/OP1/Delta receptor/DOR-1/DOPr |
|
κ |
κ1, κ2, κ3
|
KOR-1/Kappa receptor/OP2/KOP/KOPr |
spinal and supraspinal analgesia
miosis
psychotomimetic effects (dysphoria, agitation)
sedation without pronounced respiratory depression, euphoria or gastrointestinal effects
|
Nociceptin receptor |
ORL1 |
N/OFQ receptor/OP4/KOR-3/NOCIR/kappa3-related opioid receptor/MOR-C/nociceptin receptor ORL1/XOR1/NOP-r/nociceptin/orphanin FQ receptor/NOPr |
analgesia at the spinal level
reduction of locomotor activity
impairment of memory
increase of food intake
anxiolytic effect
increase of water diuresis
stimulation of immune response
|